Danaher | DHR - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.44B 9M 2026-03
Align Technology USD 864.87M 2.84M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Charles River Laboratories USD 2.84B 1.96B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
ESCO Technologies USD 1.62B 31.84M 2026-06
Fortive USD 886.9M 9.2M 2026-06
Henry Schein USD 3.26B 84M 2026-06
Illumina USD 899M 47M 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Keysight Technologies USD 1.35B 78M 2026-06
Laboratory Of America USD 3.27B 146.9M 2026-06
Medtronic USD 7.72B 436M 2026-03
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quest Diagnostics USD 2.58B 88M 2026-06
Quidel USD 646.2M 1.21B 2026-06
Repligen USD 183M 8.72M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Roper Industries USD 1.52B 1.5M 2026-06
Stryker USD 4.8B 118M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Waters USD 527M 592M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06